Actuate Therapeutics, Inc To Start Trading Tomorrow
Portfolio Pulse from Benzinga Insights
Actuate Therapeutics, Inc (NASDAQ:ACTU) will start trading on the NASDAQ exchange on August 9, 2023. The IPO price is expected to be between $8.00 and $10.00 per share, with an insider lock-up period of 180 days ending on February 5, 2025. Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for difficult-to-treat cancers.
August 08, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Actuate Therapeutics, Inc (NASDAQ:ACTU) will begin trading on the NASDAQ exchange on August 9, 2023, with shares priced between $8.00 and $10.00. The insider lock-up period will last 180 days, ending on February 5, 2025.
The IPO of Actuate Therapeutics is likely to generate significant interest given its focus on developing therapies for difficult-to-treat cancers. The initial trading days could see volatility as investors react to the new listing and the pricing range.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100